Abstract:CONSPECTUS: Inflammation and other common disorders including diabetes, cardiovascular disease, and cancer are often the result of several molecular abnormalities and are not likely to be resolved by a traditional single-target drug discovery approach. Though inflammation is a normal bodily reaction, uncontrolled and misdirected inflammation can cause inflammatory diseases such as rheumatoid arthritis and asthma. Nonsteroidal anti-inflammatory drugs including aspirin, ibuprofen, naproxen, or celecoxib are commonly used to relieve aches and pains, but often these drugs have undesirable and sometimes even fatal side effects. To facilitate safer and more effective anti-inflammatory drug discovery, a balanced treatment strategy should be developed at the biological network level. In this Account, we focus on our recent progress in modeling the inflammation-related arachidonic acid (AA) metabolic network and subsequent multiple drug design. We first constructed a mathematical model of inflammation based on experimental data and then applied the model to simulate the effects of commonly used anti-inflammatory drugs. Our results indicated that the model correctly reproduced the established bleeding and cardiovascular side effects. Multitarget optimal intervention (MTOI), a Monte Carlo simulated annealing based computational scheme, was then developed to identify key targets and optimal solutions for controlling inflammation. A number of optimal multitarget strategies were discovered that were both effective and safe and had minimal associated side effects. Experimental studies were performed to evaluate these multitarget control solutions further using different combinations of inhibitors to perturb the network. Consequently, simultaneous control of cyclooxygenase-1 and -2 and leukotriene A(4) hydrolase, as well as 5-lipoxygenase and prostaglandin E-2 synthase were found to be among the best solutions. A single compound that can bind multiple targets presents advantages including low risk of drug drug interactions and robustness regarding concentration fluctuations. Thus, we developed strategies for multiple-target drug design and successfully discovered several series of multiple-target inhibitors. Optimal solutions for a disease network often involve mild but simultaneous interventions of multiple targets, which is in accord with the philosophy of traditional Chinese medicine (TCM). To this end, our AA network model can aptly explain TCM anti-inflammatory herbs and formulas at the molecular level. We also aimed to identify activators for several enzymes that appeared to have increased activity based on MTOI outcomes. Strategies were then developed to predict potential allosteric sites and to discover enzyme activators based on our hypothesis that combined treatment with the projected activators and inhibitors could balance different AA network pathways, control inflammation, and reduce associated adverse effects. Our work demonstrates that the integration of network modeling and drug discovery can provide novel solutions for disease control, which also calls for new developments in drug design concepts and methodologies. With the rapid accumulation of quantitative data and knowledge of the molecular networks of disease, we can expect an increase in the development and use of quantitative disease models to facilitate efficient and safe drug discovery.

Development of Novel Herbal Compound Formulations Targeting Neuroinflammation: Network Pharmacology, Molecular Docking, and Experimental Verification

Natural product-based bioactive agents in combination attenuate neuroinflammation in a tri-culture model

Uncovering Potential Anti-Neuroinflammatory Components of Modified Wuziyanzong Prescription Through a Target-Directed Molecular Docking Fingerprint Strategy.

Design, Synthesis, and Biological Evaluation of Novel 3-Aminomethylindole Derivatives As Potential Multifunctional Anti-Inflammatory and Neurotrophic Agents

Design, Synthesis and Evaluation of a Series of Non-Steroidal Anti-Inflammatory Drug Conjugates As Novel Neuroinflammatory Inhibitors

Integrating network pharmacology and an experimental validation strategy elucidates the protective effect and mechanism of callicarpa nudiflora against neuroinflammation

N-Salicyloyl Tryptamine Derivatives as Potent Neuroinflammation Inhibitors by Constraining Microglia Activation via a STAT3 Pathway

Duhuo Jisheng decoction alleviates neuroinflammation and neuropathic pain by suppressing microglial M1 polarization: a network pharmacology research

Insights Into The Inhibition And Mechanism Of Compounds Against Lps-Induced Pge(2) Production: A Pathway Network-Based Approach And Molecular Dynamics Simulations

In Silico-Based Screen Synergistic Drug Combinations from Herb Medicines: a Case Using Cistanche Tubulosa

Protective Effect and Mechanism of Boswellic Acid and Myrrha Sesquiterpenes with Different Proportions of Compatibility on Neuroinflammation by LPS-Induced BV2 Cells Combined with Network Pharmacology

Mechanism of baixiangdan capsules on anti-neuroinflammation: combining dry and wet experiments

Network Pharmacology and Validation of the Combinative Therapy of Ligusticum striatum DC. and Borneolum against Cerebral Ischemia

Network pharmacology integrated with experimental validation revealed the anti-inflammatory effects of Andrographis paniculata

Accessible Method for the Development of Novel Sterol Analogues with Dipeptide-Like Side Chains That Act As Neuroinflammation Inhibitors

Synthesis And Anti-Neuroinflammatory Activity Of Lactone Benzoyl Hydrazine And 2-Nitro-1-Phenyl-1 H-Indole Derivatives As P38 Alpha Mapk Inhibitors

Synthesis of 5Α-Cholestan-6-one Derivatives and Their Inhibitory Activities of NO Production in Activated Microglia: Discovery of a Novel Neuroinflammation Inhibitor.

Drug Discovery of Neurodegenerative Disease Through Network Pharmacology Approach in Herbs

A Pair of Epimers of Lignan Alleviate Neuroinflammatory Effects by Modulating iNOS/COX-2 and MAPK/NF-κB Signaling Pathways

Diverse Ways of Perturbing the Human Arachidonic Acid Metabolic Network To Control Inflammation